Hydroxyethylamine derivatives for the treatment of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/26 (2006.01) A61K 31/4015 (2006.01) A61K 31/425 (2006.01) A61K 31/45 (2006.01) A61K 31/541 (2006.01) A61P 25/28 (2006.01) C07D 207/267 (2006.01) C07D 211/76 (2006.01) C07D 275/02 (2006.01) C07D 279/02 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2508325

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated - amyloid levels or -amyloid deposits, particularly Alzheimer's disease.

L'invention concerne de nouveaux composés d'hydroxyéthylamine de formule (I), présentant une activité inhibitrice de l'Asp2 (.beta.-sécrétase, BACE1 ou mémapsine), des procédés pour leur préparation, des compositions les contenant, ainsi que leur utilisation dans le traitement de maladies caractérisées par des taux de substances amyloïdes élevés ou des dépôts amyloïdes importants, en particulier la maladie d'Alzheimer.?¿

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hydroxyethylamine derivatives for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxyethylamine derivatives for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyethylamine derivatives for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1547174

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.